BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29978284)

  • 1. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
    N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Chuncharunee S; Wong R; Rojnuckarin P; Chang CS; Chang KM; Lu MY; Hwang WL; Koh LP; Chen TY; Leung AY; Norasetthada L; Wang SC; Chang MC; Wu KH; Issaragrisil S
    Int J Hematol; 2016 Oct; 104(4):454-61. PubMed ID: 27376944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
    Scheinberg P; Townsley D; Dumitriu B; Scheinberg P; Weinstein B; Rios O; Wu CO; Young NS
    Am J Hematol; 2014 May; 89(5):467-9. PubMed ID: 24415649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Shah S; Jain P; Shah K; Patel K; Parikh S; Patel A; Panchal H; Anand A
    Ann Hematol; 2019 Jan; 98(1):41-46. PubMed ID: 30173288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
    Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
    Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
    Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
    Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
    Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia.
    Takahashi Y; Muramatsu H; Sakata N; Hyakuna N; Hamamoto K; Kobayashi R; Ito E; Yagasaki H; Ohara A; Kikuchi A; Morimoto A; Yabe H; Kudo K; Watanabe K; Ohga S; Kojima S;
    Blood; 2013 Jan; 121(5):862-3. PubMed ID: 23372154
    [No Abstract]   [Full Text] [Related]  

  • 17. Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Song MK; Chung JS; Joo YD; Lee GW; Hong J; Park SH; Shin HJ
    Leuk Res; 2015 Mar; 39(3):284-9. PubMed ID: 25563075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Schrezenmeier H; Socié G; Marsh J; Bacigalupo A; Dührsen U; Franzke A; Hallek M; Thiel E; Wilhelm M; Höchsmann B; Barrois A; Champion K; Passweg JR
    Blood; 2011 Apr; 117(17):4434-41. PubMed ID: 21233311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.